Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Sertraline in the treatment of restricting anorexia nervosa: An open controlled trial
Autore:
Santonastaso, P; Friederici, S; Favaro, A;
Indirizzi:
Univ Padua, Dept Neurol & Psychiat Sci, Clin Psichiatr, I-35128 Padua, Italy Univ Padua Padua Italy I-35128 Sci, Clin Psichiatr, I-35128 Padua, Italy
Titolo Testata:
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
fascicolo: 2, volume: 11, anno: 2001,
pagine: 143 - 150
SICI:
1044-5463(200122)11:2<143:SITTOR>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
EATING DISORDERS; REUPTAKE INHIBITORS; NUTRITIONAL THERAPY; BULIMIA-NERVOSA; FLUOXETINE; DEPRESSION;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
28
Recensione:
Indirizzi per estratti:
Indirizzo: Favaro, A Univ Padua, Dept Neurol & Psychiat Sci, Clin Psichiatr, Via Giustiniani 3,I-35128 Padua, Italy Univ Padua Via Giustiniani 3 Padua Italy I-35128 8 Padua, Italy
Citazione:
P. Santonastaso et al., "Sertraline in the treatment of restricting anorexia nervosa: An open controlled trial", J CH AD PSY, 11(2), 2001, pp. 143-150

Abstract

Few studies to date have examined the usefulness of selective serotonin reuptake inhibitors (SSRIs) in an outpatient multidisciplinary treatment of anoxrexia nervosa. The present study consists of an open, controlled trial of sertraline in a sample of 11 restricting-type anorexics, treated in an outpatient setting, compared with a control group of patients with similar characteristics. All subjects were assessed by means of a structured interview and self-reported questionnaires at baseline and after 14 weeks of treatment. Body weight and diagnostic status were evaluated again after a 64-weekfollow-up. At the 14-week follow-up, the sertraline group reported a significantly greater improvement of depressive symptoms, ineffectiveness, lack of interoceptive awareness, and perfectionism when compared to the control group. Both groups reported a significant improvement in body weight. At the 64-week follow-up, only one patient of the sertraline group and five patients of the control group still had a full diagnosis of an eating disorder. Further studies are necessary to define the role of sertraline and of other SSRIs in the treatment of anorexia nervosa.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/20 alle ore 01:31:10